The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ghemaxan 15,000 IU (150 mg)/1 mL solution for injection in pre-filled syringes



Chemi S.p.A.PA22937/001/007

Main Information

Trade NameGhemaxan 15,000 IU (150 mg)/1 mL solution for injection in pre-filled syringes
Active SubstancesEnoxaparin Sodium
Dosage FormSolution for injection in pre-filled syringe
Licence HolderChemi S.p.A.
Licence NumberPA22937/001/007

Group Information

ATC CodeB01AB05 enoxaparin

Status

License statusAuthorised
Licence Issued19/06/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back